A detailed history of Abbrea Capital, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Abbrea Capital, LLC holds 62,142 shares of PFE stock, worth $1.56 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares
62,142
Previous 66,662 6.78%
Holding current value
$1.56 Million
Previous $1.85 Million 6.0%
% of portfolio
0.23%
Previous 0.24%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

SELL
$25.26 - $29.6 $114,175 - $133,792
-4,520 Reduced 6.78%
62,142 $1.74 Million
Q1 2024

May 07, 2024

SELL
$25.89 - $29.73 $211,184 - $242,507
-8,157 Reduced 10.9%
66,662 $1.85 Million
Q4 2023

Feb 02, 2024

SELL
$26.13 - $33.94 $372,352 - $483,644
-14,250 Reduced 16.0%
74,819 $2.15 Million
Q3 2023

Oct 31, 2023

SELL
$32.09 - $37.51 $10,846 - $12,678
-338 Reduced 0.38%
89,069 $2.95 Million
Q2 2023

Aug 01, 2023

BUY
$36.12 - $41.79 $16,831 - $19,474
466 Added 0.52%
89,407 $3.28 Million
Q1 2023

May 11, 2023

SELL
$39.39 - $51.28 $52,270 - $68,048
-1,327 Reduced 1.47%
88,941 $3.63 Million
Q4 2022

Feb 08, 2023

BUY
$41.75 - $54.5 $65,130 - $85,020
1,560 Added 1.76%
90,268 $4.63 Million
Q3 2022

Nov 03, 2022

SELL
$43.76 - $53.42 $181,297 - $221,319
-4,143 Reduced 4.46%
88,708 $3.88 Million
Q2 2022

Aug 02, 2022

BUY
$46.53 - $55.17 $5,304 - $6,289
114 Added 0.12%
92,851 $4.87 Million
Q1 2022

May 11, 2022

BUY
$45.75 - $56.69 $59,475 - $73,697
1,300 Added 1.42%
92,737 $4.8 Million
Q4 2021

Feb 04, 2022

BUY
$41.32 - $61.25 $14,875 - $22,050
360 Added 0.4%
91,437 $5.4 Million
Q3 2021

Nov 04, 2021

BUY
$39.25 - $50.42 $117,161 - $150,503
2,985 Added 3.39%
91,077 $3.92 Million
Q2 2021

Aug 04, 2021

BUY
$35.91 - $40.68 $265,949 - $301,276
7,406 Added 9.18%
88,092 $3.45 Million
Q1 2021

May 13, 2021

BUY
$33.49 - $37.77 $116,880 - $131,817
3,490 Added 4.52%
80,686 $2.92 Million
Q4 2020

Jan 21, 2021

BUY
$33.47 - $42.56 $133,612 - $169,899
3,992 Added 5.45%
77,196 $2.84 Million
Q3 2020

Oct 20, 2020

BUY
$31.75 - $37.25 $22,542 - $26,447
710 Added 0.98%
73,204 $2.69 Million
Q2 2020

Aug 11, 2020

SELL
$30.12 - $36.54 $25,903 - $31,424
-860 Reduced 1.17%
72,494 $2.37 Million
Q1 2020

Apr 29, 2020

SELL
$27.03 - $38.62 $48,545 - $69,361
-1,796 Reduced 2.39%
73,354 $2.39 Million
Q4 2019

Feb 11, 2020

SELL
$32.92 - $37.36 $81,806 - $92,839
-2,485 Reduced 3.2%
75,150 $2.94 Million
Q3 2019

Nov 07, 2019

SELL
$32.49 - $42.13 $17,382 - $22,539
-535 Reduced 0.68%
77,635 $2.79 Million
Q2 2019

Jul 31, 2019

BUY
$36.98 - $41.52 $443,316 - $497,741
11,988 Added 18.11%
78,170 $3.39 Million
Q1 2019

May 08, 2019

BUY
$37.5 - $41.2 $56,812 - $62,418
1,515 Added 2.34%
66,182 $2.81 Million
Q4 2018

Feb 05, 2019

BUY
$38.47 - $43.86 $122,411 - $139,562
3,182 Added 5.18%
64,667 $2.82 Million
Q3 2018

Nov 09, 2018

SELL
$34.47 - $41.81 $101,169 - $122,712
-2,935 Reduced 4.56%
61,485 $2.71 Million
Q2 2018

Aug 08, 2018

BUY
$32.98 - $35.16 $42,016 - $44,793
1,274 Added 2.02%
64,420 $2.34 Million
Q1 2018

May 10, 2018

BUY
$31.91 - $37.02 $128,724 - $149,338
4,034 Added 6.82%
63,146 $2.24 Million
Q4 2017

Feb 01, 2018

BUY
$33.26 - $35.29 $178,074 - $188,942
5,354 Added 9.96%
59,112 $2.14 Million
Q3 2017

Nov 07, 2017

BUY
$31.0 - $34.15 $1.67 Million - $1.84 Million
53,758
53,758 $1.92 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $141B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Abbrea Capital, LLC Portfolio

Follow Abbrea Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Abbrea Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Abbrea Capital, LLC with notifications on news.